Kenvue said Monday that its board was taking steps to realize shareholder value and allow the company to “reach its full ...

Mongon’s departure follows the appointment of a new chief financial ... the company delivers its full quarterly earnings in early August. The post Kenvue stock rises on CEO exit as company launches ...

Kenvue named director Kirk Perry as interim CEO, while Mongon also stepped down from the board. Perry, who worked at Procter & Gamble (PG.N) for 23 years, most recently served as CEO of technology ...

Kenvue, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio amid a recent ...

Kenvue, which makes powerhouse consumer health brands such as Listerine mouthwash and pain reliever Tylenol, saw its second-quarter sales slip 4%, the company also reported on Monday.

Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors is implementing a set of actions to enable the Company to unlock shareholder value and r ...

Kenvue announced a major change at the top July 14, along with actions to “unlock shareholder value and reach its full potential.” CEO Thibaut Mongon has departed the Summit-based company and ...

U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

Kenvue says that Thibaut Mongon is stepping down as its CEO as the maker of Listerine and Band-Aid brands continues with a strategic review of the company. Kenvue used to ...

Kenvue CEO steps down amid poor performance and ongoing strategic review. High debt load and rising rates strain Kenvue’s free cash flow and dividend sustainability. Net debt-to-EBITDA at 3.06x ...

Kenvue KVUE 2.01%, the Johnson & Johnson spinoff that makes Tylenol and Benadryl, said Chief Executive Thibaut Mongon has departed and that the company is considering simplifying its portfolio ...

Reuters FILE PHOTO: Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson's consumer-health business, speaks during an interview with CNBC during his company's IPO at the New York Stock Exchange ...